SCHEMBL24878379

SCHEMBL24878379

CC(C)c1cc(C2CC2)nn(-c2ccc(F)cc2)c1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNJ6 P48051 4/20 0.38
▸ KCNJ3 P48549 4/20 0.38
▸ MET P08581 1/20 0.38
▸ AXL P30530 1/20 0.38
▸ TYRO3 Q06418 1/20 0.38
▸ MERTK Q12866 1/20 0.38
▸ PPARA Q07869 2/20 0.36
▸ CRACR2A Q9BSW2 3/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ KCNJ5 P48544 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ ABHD16A O95870 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21785854 0.80 ALDH1A1 (0.41) KCNJ6KCNJ3METAXLTYRO3
SCHEMBL21785859 0.79 PPARA (0.43) KCNJ6KCNJ3PPARAALDH1A1L3MBTL1
SCHEMBL21777246 0.76 KCNJ6 (0.45) KCNJ6KCNJ3METAXLTYRO3
SCHEMBL24878426 0.72 KCNH2 (0.41) METAXLTYRO3MERTKMEN1
SCHEMBL24878378 0.70 ALDH1A1 (0.44) METALDH1A1L3MBTL1NPC1LMNA
SCHEMBL18692223 0.68 NPC1 (0.68) KCNJ6KCNJ3L3MBTL1MEN1KMT2A
SCHEMBL26084041 0.67 KCNJ6 (0.44) KCNJ6KCNJ3ALDH1A1L3MBTL1MEN1
SCHEMBL12298699 0.67 PPARA (0.46) KCNJ6KCNJ3PPARACRACR2AKCNJ5
SCHEMBL24878428 0.66 KCNH2 (0.46) MEN1KMT2ANPC1LMNARAB9A
SCHEMBL21786037 0.65 PPARA (0.52) KCNJ6KCNJ3METAXLTYRO3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3843850-B1 PYRAZOLO[3,4-B]PYRIDINE COMPOUNDS AS INHIBITORS OF TAM AND MET KINASES ARRAY BIOPHARMA INC (US) 2023-11-15 — — EP disclosed
US-11780835-B2 Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases ARRAY BIOPHARMA INC. (US) 2023-10-10 — — US disclosed
US-11780835-B2 Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases ARRAY BIOPHARMA INC. (US) 2023-10-10 — — US disclosed
US-20230011441-A1 PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS AS INHIBITORS OF TAM AND MET KINASES ARRAY BIOPHARMA INC. (US) 2023-01-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230011441-A1 PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS AS INHIBITORS OF TAM AND MET KINASES RET, MERTK, MET KCNJ6 2037/4885KCNJ3 1542/4885MET 3/4885
US-11780835-B2 Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases RET, MERTK, MET KCNJ6 2037/4885KCNJ3 1542/4885MET 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback